For clinicians & researchers

A platform for thoughtful clinical collaboration.

Explore the clinical context, research direction and responsible pathway for DBS in drug addiction.

For clinicians & researchers

Advancing evidence through clinical partnership.

We welcome professionally appropriate dialogue with clinicians, researchers and healthcare institutions interested in the evolving field of neuromodulation for addiction.

01 / EVIDENCE

Clinical context

DBS for addiction requires careful patient selection, multidisciplinary assessment and rigorous clinical governance.

02 / COLLABORATION

Research dialogue

Share questions, academic perspectives and opportunities for responsible scientific exchange.

03 / REFERRAL

Patient evaluation

A referral does not determine eligibility; each case requires review by the responsible treating team.

Editorial perspective

Evidence is built through careful observation.

Research questions, clinical measures and long-term follow-up all contribute to responsible dialogue in this evolving field.

Read the clinical observations →

Clinical innovation is meaningful only when scientific rigour, patient safety and long-term care remain central.

Editorial perspective

Different disciplines, one shared responsibility.

Neuroscience, addiction medicine and mental-health care each bring a necessary perspective to clinical collaboration.

For clinicians & researchers

Connect with the professional team

Professional enquiries

This page is for general professional information and is not a clinical protocol or treatment recommendation.

From evidence to dialogue

Clinical collaboration is built on questions, evidence and care.

The pathway brings together neuroscience, addiction medicine, psychiatry and long-term follow-up. Our professional resources support informed, responsible exchange rather than simplified conclusions.

This information is educational and does not replace local clinical governance, ethical review or treatment protocols.

Scroll to Top